Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: (IMO only) Carlton Johnson

How about this

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

TO SECTION 13 0R 15 (D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported) June 12, 2008

Alternative Construction Technologies, Inc.

ITEM 5.02 DEPARTURE OF CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.

On June 12, 2008, the Company announced the appointment of two directors, Thomas Dawe and Carlton M. Johnson. These directors were appointed in connection with the recent financing with Bridgepointe Master Fund, Ltd. and CAMOFI Master LDC (the “Lenders”). In connection with that financing, the Lenders retained the right to recommend two nominees to the Company’s Board of Directors. The Lenders recommended Mssrs Dawe and Johnson to these positions and the Company’s Board of Directors approved their appointment. The Company and its Board of Directors also agreed to use their best efforts to obtain shareholder ratification of the appointment of the new directors at the next shareholder meeting. After any and all amounts due and owing under all of the Notes issued in connection with the financing have been repaid in full or after the Maturity Date, whichever is later, the Company agreed to allow these directors to rotate off of the Company’s Board of Directors after they serve out the remainder of their terms (but the directors are not required to resign). The Company also agreed to execute Conflict Waiver and Acknowledgements that the directors, shall be subject to a “Chinese Wall”, meaning that inside nonpublic information that the directors shall possess will not be imputed in any way whatsoever to the Lenders.

Mr. Dawe has, since September 2006, been a Senior Investment Officer of Roswell Capital Partnetrs, LLC (“Roswell”), Alpharetta, GA, responsible for negotiating, analyzing, structuring and closing private placement transactions for micro-cap public companies seeking growth capital. From July 2001 to September 2006, he was a Senior Vice President - Institutional Equity for Prudential Equity Group, responsible for working with the Chief Investment Officers of 62 large to mid-sized institutional clients to develop investment strategies for the public equity markets. Mr. Dawe graduated from the University of Virginia in 1981 with a Bachelor of Arts degree and, in 1984, from the University of Virginia’s Darden School of Business with an MBA.

Mr. Johnson has been In-House Legal Counsel since joining Roswell in April of 1996. His responsibilities include general corporate, securities law, business litigation, and corporate governance. Mr. Johnson has been a member of the Alabama Bar since 1986, the Florida Bar since 1988, and the State Bar of Georgia since 1997. Mr. Johnson earned a degree in History/Political Science at Auburn University in 1982 and Juris Doctorate at Samford University - Cumberland School of Law in 1986. He has served on the Board of Directors for Peregrine Pharmaceuticals Inc., an emerging biotech company, since 1999 where he is the Chair of their Audit Committee. Since 2001, Mr. Johnson has also served on the Board of Directors of Patriot Scientific, Inc. an intellectual property holding and licensing company. He is Chair of the Compensation Committee and serves on the Audit Committee, as well as the Executive Committee

http://google.brand.edgar-online.com/DisplayFilingInfo.aspx?Type=HTML&text=%2526lt%253bNEAR%252f4%2526gt%253b(%22CARLTON+M%22%2c%22JOHNSON%22)+%2526lt%253bOR%2526gt%253b+%2526lt%253bNEAR%252f4%2526gt%253b(%22CARLTON+M.%22%2c%22JOHNSON%22)&FilingID=5994270&ppu=%2fPeopleFilingResults.aspx%3fPersonID%3d2507223%26PersonName%3dCARLTON%2520M.%2520JOHNSON

Share
New Message
Please login to post a reply